EURON VENTURE GROUP AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: WA
Waqas Aziz Malik1984
Chairman of the board: NH
Nils Haga1962
Years since formation: 4 years; since Jan 19, 2021
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 133,686; 1 share class
Total number of shareholders: 10; 4 companies, 6 persons
Belongs to group of

Financials

Total operating income 2023: 305,931; NOK
Annual total result 2023: -1,580,857; NOK
Total equity 2023: -1,871,187; NOK

Last update: Apr 22, 2025

Management

Management / administration

Name	Role	Shares
WA Waqas Aziz Malik 1984	Managing Director/CEO	-

Board

Name	Role	Shares
WA Waqas Aziz Malik 1984	Board Member	-
NH Nils Haga 1962	Chairman	-

Others

Name	Role	Shares
M MR ØKONOMI AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
KS Kenneth Sanders 1987	-	22.58 % indirectly
VM Vaghei Malik Mona 1985	-	15.48 % indirectly
AM Aziz Malik Waqas 1984	-	15.48 % indirectly
RQ Ralph Quimpo Rosell 1989	-	12.34 % directly
MI Mohammad Ibrar Aslam 1980	-	10 % indirectly
GA Gustavo Adolfo Arias 1976	-	7.48 % directly
PC Peder Coucheron Støre 1981	-	3.74 % directly
JH Javeed Hussain Shah 1980	-	3.74 % indirectly
SS Samira Shibly Engebakk 1989	-	3.74 % directly
XS Xu Shengda 1968	-	3.34 % directly

Last update: May 27, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
W WOM INVEST AS	Ordinary shares	41,385	30.96 %
S SANDERS HOLDING AS	Ordinary shares	31,500	23.56 %
RQ Ralph Quimpo Rosell 1989	Ordinary shares	16,500	12.34 %
I I.A HOLDING AS	Ordinary shares	13,375	10 %
GA Gustavo Adolfo Arias 1976	Ordinary shares	10,000	7.48 %
PC Peder Coucheron Støre 1981	Ordinary shares	5,000	3.74 %
S SHAH HOLDING AS	Ordinary shares	5,000	3.74 %
SS Samira Shibly Engebakk 1989	Ordinary shares	5,000	3.74 %
XS Xu Shengda 1968	Ordinary shares	4,461	3.34 %
TC Thilesen Christoffer 1988	Ordinary shares	1,465	1.1 %

Shares owned by the EURON VENTURE GROUP AS

Name	Share class	Total number of shares	Share
E EURON CONNECT AS	Ordinary shares	30,000	100 %
E EURONLABS AS	Ordinary shares	30,000	100 %
P PEGAZEUS AS	Ordinary shares	2,790,000	93 %

Last update: Jun 2, 2025

Group structure

EURON VENTURE GROUP AS
Total operating income 2023: NOK 305,931
Operating profit 2023: NOK -1,521,404
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	305,931	39,024	0
Annual Total Result	-1,580,857	-383,097	-2,131
Total assets	2,577,786	269,704	97,869
Total liabilities	4,448,973	560,034	5,570
Total equity	-1,871,187	-290,330	92,299

P&L

Year	2023	2022	2021
Total operating income	305,931	39,024	0
Total operating costs	1,827,335	421,760	2,131
Operating result	-1,521,404	-382,737	-2,131
Financial income/costs	-59,452	108	0
Profit before tax	-1,580,857	-382,629	-2,131
Total tax & extraordinary income/cost	0	468	0
Annual Total Result	-1,580,857	-383,097	-2,131

Balance overview

Year	2023	2022	2021
Total fixed assets	903,863	21,155	0
Total current assets	1,673,923	248,549	97,869
Total assets	2,577,786	269,704	97,869
Short term debt	2,603,973	182,034	5,570
Long term debt	0	0	0
Total liabilities	4,448,973	560,034	5,570
Contributed capital	100,000	100,000	100,000
Retained earnings	-1,971,187	-390,330	-7,701
Total equity	-1,871,187	-290,330	92,299
Total equity and liabilities	2,577,786	269,704	97,869

EURON VENTURE GROUP AS926 330 292